4//SEC Filing
Kaplan Matthew L. 4
Accession 0001104659-25-058919
CIK 0001875558other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:31 PM ET
Size
4.9 KB
Accession
0001104659-25-058919
Insider Transaction Report
Form 4
Kaplan Matthew L.
Director
Transactions
- Award
Common Stock
2025-06-12+30,000→ 113,760 total
Footnotes (1)
- [F1]The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Kaplan's continued service on the Company's Board of Directors on such dates.
Documents
Issuer
Nuvectis Pharma, Inc.
CIK 0001875558
Entity typeother
Related Parties
1- filerCIK 0001895952
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:31 PM ET
- Size
- 4.9 KB